(Q33703271)

28 July 2017

title

Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo (English)

1 reference

28 July 2017

1 reference

1 reference

Anning Yin

1

1 reference

28 July 2017

Yingan Jiang

2

1 reference

28 July 2017

Xianfeng Zhang

3

1 reference

28 July 2017

Juan Zhao

4

1 reference

28 July 2017

Hesheng Luo

5

1 reference

28 July 2017

language of work or name

English

0 references

publication date

24 September 2010

1 reference

full work available at URL

28 July 2017

https://api.elsevier.com/content/article/PII:S0014299910009258?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

https://api.elsevier.com/content/article/PII:S0014299910009258?httpAccept=text/plain

20 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

European Journal of Pharmacology

20 July 2024

published in

1 reference

28 July 2017

volume

649

1 reference

28 July 2017

issue

1-3

1 reference

28 July 2017

page(s)

120-126

1 reference

https://opencitations.net/index/coci/api/v1/citations/10.3322/CAAC.20006

28 July 2017

cites work

Cancer statistics, 2009

1 reference

28 May 2022

Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracrani

1

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression

20 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo

20 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Combined 5-fluorouracil/systemic interferon-beta gene therapy results in long-term survival in mice with established colorectal liver metastases

20 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Cisplatin: from DNA damage to cancer chemotherapy.

20 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis

20 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus

20 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Principles and applications of gene therapy in colon cancer

20 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Rates and predictors of chemotherapy use for stage III colon cancer: a systematic review

20 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Promoting apoptosis as a strategy for cancer drug discovery

20 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Gene-Expression Profiles in Hereditary Breast Cancer

20 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer

20 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer

20 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells

20 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistance

20 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue

20 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal

20 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

20 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas

20 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Advances in chemotherapy against advanced or metastatic colorectal cancer

20 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats

20 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c

20 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia

20 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Transfer of anti-TFAR19 monoclonal antibody into HeLa cells by in situ electroporation can inhibit the apoptosis

20 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Synergetic effects of retrovirus IFN-alpha gene transfer and 5-FU on apoptosis of colon cancer cells

20 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Cisplatin: mode of cytotoxic action and molecular basis of resistance

20 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin

20 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Association of thePDCD5Locus With Lung Cancer Risk and Prognosis in Smokers

20 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

20 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

20 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Cellular processing of platinum anticancer drugs

20 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression

20 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Systemic treatment of colorectal cancer

20 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver

20 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells

20 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.09.040

20 July 2024

Identifiers

1 reference

28 July 2017

1 reference